About Thomas Cahill
Form D filings for Autobahn Therapeutics in 2024 list Thomas Cahill as director.
Thomas Cahill first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Cahill in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Cahill works with at each company, as listed on that company's latest Form D.
Autobahn Therapeutics, Inc. · Form D, Aug 1, 2024
US
Uwe Schoenbeck
Director
JB
John Borkholder
Secretary
KB
Kristina Burow
Director
TA
Timothy Anderson
Director
PD
Philip DeSouza
Director
BC
Benjamin Cravatt
Director
SG
Scott Giacobello
Director
KF
Kevin Finney
Executive officer and director
BW
Bonnie van Wilgenburg
Director